ZA9710653B - 4-hydroxy-piperidine derivatives. - Google Patents

4-hydroxy-piperidine derivatives.

Info

Publication number
ZA9710653B
ZA9710653B ZA9710653A ZA9710653A ZA9710653B ZA 9710653 B ZA9710653 B ZA 9710653B ZA 9710653 A ZA9710653 A ZA 9710653A ZA 9710653 A ZA9710653 A ZA 9710653A ZA 9710653 B ZA9710653 B ZA 9710653B
Authority
ZA
South Africa
Prior art keywords
hydroxy
piperidine derivatives
piperidine
derivatives
Prior art date
Application number
ZA9710653A
Other languages
English (en)
Inventor
Alexander Alanine
Marie-Paule Heitz Neidhart
Rene Wyler
Bernd Buettelmann
Emmanuel Pinard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA9710653B publication Critical patent/ZA9710653B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9710653A 1996-12-03 1997-11-26 4-hydroxy-piperidine derivatives. ZA9710653B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96119345 1996-12-03

Publications (1)

Publication Number Publication Date
ZA9710653B true ZA9710653B (en) 1998-06-03

Family

ID=8223458

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710653A ZA9710653B (en) 1996-12-03 1997-11-26 4-hydroxy-piperidine derivatives.

Country Status (29)

Country Link
US (1) US6359138B1 (cs)
JP (1) JP3045988B2 (cs)
KR (1) KR100257947B1 (cs)
CN (2) CN1162425C (cs)
AR (1) AR009641A1 (cs)
AT (1) ATE205830T1 (cs)
AU (1) AU736597B2 (cs)
BR (1) BR9705509B1 (cs)
CA (1) CA2220649C (cs)
CO (1) CO4910155A1 (cs)
CZ (1) CZ376997A3 (cs)
DE (1) DE69706813T2 (cs)
DK (1) DK0846683T3 (cs)
ES (1) ES2163086T3 (cs)
HR (1) HRP970653B1 (cs)
ID (1) ID17678A (cs)
IL (1) IL122352A0 (cs)
MA (1) MA24410A1 (cs)
NO (1) NO975541L (cs)
NZ (1) NZ329271A (cs)
PE (1) PE20499A1 (cs)
PL (1) PL323447A1 (cs)
PT (1) PT846683E (cs)
RU (1) RU2184112C2 (cs)
SG (1) SG71062A1 (cs)
TR (1) TR199701488A2 (cs)
UY (1) UY24797A1 (cs)
YU (1) YU46997A (cs)
ZA (1) ZA9710653B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227197B1 (en) * 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
US7005432B2 (en) * 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
EP1600447A1 (en) * 2004-05-28 2005-11-30 Neuropharma S.A.U. Butyrylcholinesterase selective inhibitors
HUP0401522A2 (en) * 2004-07-29 2006-04-28 Richter Gedeon Vegyeszet New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
TW200621677A (en) * 2004-09-21 2006-07-01 Astellas Pharma Inc Cyclic amine derivative or salt thereof
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
RU2538982C1 (ru) * 2013-11-19 2015-01-10 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Нижегородский Государственный Университет Им. Н.И. Лобачевского" Производное n-(1s)-1',2',3'-триметокси-6,7-дигидро-1н-бензо[5',6':5,4]циклогепта-[3,2-f]бензофуран-1-ил)ацетамида и его применение
EP3233077B1 (en) 2014-12-19 2026-05-06 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE546389C (de) 1927-12-30 1932-03-14 Ralph Mayhew Vorrichtung zur Bedienung von Tasteninstrumenten
US3476760A (en) 1967-03-06 1969-11-04 Smithkline Corp Substituted piperidinoalkylthianaphthenes and benzofurans
US3506671A (en) * 1967-11-01 1970-04-14 Smithkline Corp 1-naphthylalkyl-4-phenylpiperidine derivatives
US3557123A (en) * 1967-11-01 1971-01-19 Smith Kline French Lab 1-naphthylalkyl-4-phenylpiperidine derivatives
DE2507782A1 (de) 1975-02-22 1976-09-02 Merck Patent Gmbh Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung
US4016281A (en) 1975-02-22 1977-04-05 Merck Patent Gesellschaft Mit Beschrankter Haftung Tetralone and indanone compounds
US4039676A (en) 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
EP0192522B1 (fr) * 1985-02-01 1988-08-31 LABORATOIRE L. LAFON Société anonyme dite: 1-ethyl - 3-hydroxy-3-phénylpipéridine, procédé de préparation et utilisation en thérapeutique
GB8515388D0 (en) 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
GB8515389D0 (en) 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
RU2068414C1 (ru) 1990-05-10 1996-10-27 Пфайзер Инк. Производные индолона в виде рацемата или оптически активного изомера или их фармацевтически приемлемые аддитивные соли кислоты и кетопроизводные индолона
CZ284133B6 (cs) * 1991-07-17 1998-08-12 Pfizer Inc. 2-/4-Hydroxypiperidino/-1-alkanolové deriváty jako antiischemická činidla. způsob jejich přípravy a použití.
DE4140542A1 (de) 1991-12-09 1993-06-17 Bayer Ag Piperdylmethyl substituierte chormanderivate
US5436255A (en) 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors

Also Published As

Publication number Publication date
NZ329271A (en) 1998-12-23
PL323447A1 (en) 1998-06-08
PT846683E (pt) 2002-02-28
CN1086702C (zh) 2002-06-26
JPH10168060A (ja) 1998-06-23
BR9705509A (pt) 2000-03-14
UY24797A1 (es) 2000-12-29
CN1349989A (zh) 2002-05-22
DE69706813T2 (de) 2002-04-04
IL122352A0 (en) 1998-04-05
KR19980063726A (ko) 1998-10-07
CN1162425C (zh) 2004-08-18
HRP970653B1 (en) 2001-12-31
AR009641A1 (es) 2000-04-26
PE20499A1 (es) 1999-03-05
RU2184112C2 (ru) 2002-06-27
NO975541D0 (no) 1997-12-02
NO975541L (no) 1998-06-04
SG71062A1 (en) 2000-03-21
CN1188111A (zh) 1998-07-22
DE69706813D1 (de) 2001-10-25
ES2163086T3 (es) 2002-01-16
HK1011859A1 (en) 1999-07-23
AU736597B2 (en) 2001-08-02
DK0846683T3 (da) 2001-11-05
YU46997A (sh) 2000-12-28
AU4684197A (en) 1998-06-04
TR199701488A2 (xx) 1998-06-22
CA2220649C (en) 2007-02-13
ATE205830T1 (de) 2001-10-15
HRP970653A2 (en) 1998-10-31
CO4910155A1 (es) 2000-04-24
MA24410A1 (fr) 1998-07-01
KR100257947B1 (ko) 2000-07-01
US6359138B1 (en) 2002-03-19
CZ376997A3 (cs) 1998-06-17
ID17678A (id) 1998-01-22
BR9705509B1 (pt) 2009-01-13
JP3045988B2 (ja) 2000-05-29
CA2220649A1 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
ZA976224B (en) 4-hydroxy-piperidine derivatives.
ZA97521B (en) 19-Nor-pregnene derivatives.
HRP970454B1 (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA977206B (en) Arylalkanoylpyridazines.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA979781B (en) Piperidine derivatives.
ZA979725B (en) Benzoaxozole derivative.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
HRP970653B1 (en) 4-hydroxy-piperidine derivatives
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
ZA97672B (en) Tetrahydroisoquinoline derivatives.
ZA978332B (en) 1-carba-(dethia)-cephalosporin derivatives.